IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry).

MLA

Bielak, M., et al. “IL-6 Blockade in Systemic Juvenile Idiopathic Arthritis – Achievement of Inactive Disease and Remission (Data from the German AID-Registry).” Pediatric Rheumatology, vol. 16, Apr. 2018, p. 1. EBSCOhost, https://doi.org/10.1186/s12969-018-0236-y.

APA

Bielak, M., Husmann, E., Weyandt, N., Haas, J.-P., Hügle, B., Horneff, G., Neudorf, U., Lutz, T., Lilienthal, E., Kallinich, T., Tenbrock, K., Berendes, R., Niehues, T., Wittkowski, H., Weißbarth-Riedel, E., Heubner, G., Oommen, P., Klotsche, J., Foell, D., & Lainka, E. (2018). IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry). Pediatric Rheumatology, 16, 1. https://doi.org/10.1186/s12969-018-0236-y

Chicago

Bielak, M., E. Husmann, N. Weyandt, J.-P. Haas, B. Hügle, G. Horneff, U. Neudorf, et al. 2018. “IL-6 Blockade in Systemic Juvenile Idiopathic Arthritis – Achievement of Inactive Disease and Remission (Data from the German AID-Registry).” Pediatric Rheumatology 16 (April): 1. doi:10.1186/s12969-018-0236-y.